Aug 10 (Reuters) - Achieve Life Sciences Inc ACHV.O -
* Achieve announces FDA acceptance of the investigational new drug application (IND) for cytisine as a smoking cessation treatment
* Achieve Life Sciences Inc- achieve expects to commence a phase 3 trial of cytisine in united states in first-half of 2018